Myelomatous Involvement of the Central Nervous System

Jonas Paludo; Utkarsh Painuly; Shaji K Kumar; Wilson Gonsalves; S Vincent Rajkumar; Francis Buadi; Martha Lacy; Angela Dispenzieri; Robert A. Kyle; Michelle M Mauermann; Arleigh McCurdy; David M Dingli; Ronald S. Go; Suzanne R. Hayman; Nelson Leung; John A. Lust; Yi Lin; Morie Gertz; Prashant Kapoor

doi:10.1016/j.clml.2016.08.010

Myelomatous Involvement of the Central Nervous System

Jonas Paludo, Utkarsh Painuly, Shaji K Kumar, Wilson Gonsalves, S Vincent Rajkumar, Francis Buadi, Martha Lacy, Angela Dispenzieri, Robert A. Kyle, Michelle M Mauermann, Arleigh McCurdy, David M Dingli, Ronald S. Go, Suzanne R. Hayman, Nelson Leung, John A. Lust, Yi Lin, Morie Gertz, Prashant Kapoor

Research output: Contribution to journal › Article › peer-review

14 Scopus citations

Abstract

Micro-Abstract Myelomatous involvement of the central nervous system (CNS) is an uncommon complication that portends a poor prognosis in patients with multiple myeloma (MM). Limited data exist regarding the optimal management of CNS MM. In the present case-control study, we examined the clinical presentation, diagnosis, treatment, and outcomes of CNS MM patients compared with a control group of MM patients without CNS involvement, matched by date of diagnosis and gender.

Original language	English (US)
Pages (from-to)	644-654
Number of pages	11
Journal	Clinical Lymphoma, Myeloma and Leukemia
Volume	16
Issue number	11
DOIs	https://doi.org/10.1016/j.clml.2016.08.010
State	Published - Nov 1 2016

Keywords

Extramedullary
High-risk
Leptomeningeal
Multiple myeloma
Outcome

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.1016/j.clml.2016.08.010

Fingerprint Dive into the research topics of 'Myelomatous Involvement of the Central Nervous System'. Together they form a unique fingerprint.

Cite this

Paludo, J., Painuly, U., Kumar, S. K., Gonsalves, W., Rajkumar, S. V., Buadi, F., Lacy, M., Dispenzieri, A., Kyle, R. A., Mauermann, M. M., McCurdy, A., Dingli, D. M., Go, R. S., Hayman, S. R., Leung, N., Lust, J. A., Lin, Y., Gertz, M., & Kapoor, P. (2016). Myelomatous Involvement of the Central Nervous System. Clinical Lymphoma, Myeloma and Leukemia, 16(11), 644-654. https://doi.org/10.1016/j.clml.2016.08.010

Myelomatous Involvement of the Central Nervous System. / Paludo, Jonas; Painuly, Utkarsh; Kumar, Shaji K ; Gonsalves, Wilson ; Rajkumar, S Vincent; Buadi, Francis; Lacy, Martha ; Dispenzieri, Angela; Kyle, Robert A.; Mauermann, Michelle M; McCurdy, Arleigh; Dingli, David M; Go, Ronald S.; Hayman, Suzanne R.; Leung, Nelson; Lust, John A.; Lin, Yi ; Gertz, Morie ; Kapoor, Prashant.

In: Clinical Lymphoma, Myeloma and Leukemia, Vol. 16, No. 11, 01.11.2016, p. 644-654.

Research output: Contribution to journal › Article › peer-review

Paludo, J, Painuly, U, Kumar, SK , Gonsalves, W , Rajkumar, SV, Buadi, F, Lacy, M , Dispenzieri, A, Kyle, RA, Mauermann, MM, McCurdy, A, Dingli, DM, Go, RS, Hayman, SR, Leung, N, Lust, JA, Lin, Y , Gertz, M & Kapoor, P 2016, 'Myelomatous Involvement of the Central Nervous System', Clinical Lymphoma, Myeloma and Leukemia, vol. 16, no. 11, pp. 644-654. https://doi.org/10.1016/j.clml.2016.08.010

Paludo, Jonas ; Painuly, Utkarsh ; Kumar, Shaji K ; Gonsalves, Wilson ; Rajkumar, S Vincent ; Buadi, Francis ; Lacy, Martha ; Dispenzieri, Angela ; Kyle, Robert A. ; Mauermann, Michelle M ; McCurdy, Arleigh ; Dingli, David M ; Go, Ronald S. ; Hayman, Suzanne R. ; Leung, Nelson ; Lust, John A. ; Lin, Yi ; Gertz, Morie ; Kapoor, Prashant. / Myelomatous Involvement of the Central Nervous System. In: Clinical Lymphoma, Myeloma and Leukemia. 2016 ; Vol. 16, No. 11. pp. 644-654.

@article{5e31d548ab274eec84cf13a76436daed,

title = "Myelomatous Involvement of the Central Nervous System",

abstract = "Micro-Abstract Myelomatous involvement of the central nervous system (CNS) is an uncommon complication that portends a poor prognosis in patients with multiple myeloma (MM). Limited data exist regarding the optimal management of CNS MM. In the present case-control study, we examined the clinical presentation, diagnosis, treatment, and outcomes of CNS MM patients compared with a control group of MM patients without CNS involvement, matched by date of diagnosis and gender.",

keywords = "Extramedullary, High-risk, Leptomeningeal, Multiple myeloma, Outcome",

author = "Jonas Paludo and Utkarsh Painuly and Kumar, {Shaji K} and Wilson Gonsalves and Rajkumar, {S Vincent} and Francis Buadi and Martha Lacy and Angela Dispenzieri and Kyle, {Robert A.} and Mauermann, {Michelle M} and Arleigh McCurdy and Dingli, {David M} and Go, {Ronald S.} and Hayman, {Suzanne R.} and Nelson Leung and Lust, {John A.} and Yi Lin and Morie Gertz and Prashant Kapoor",

year = "2016",

month = nov,

day = "1",

doi = "10.1016/j.clml.2016.08.010",

language = "English (US)",

volume = "16",

pages = "644--654",

journal = "Clinical Lymphoma, Myeloma and Leukemia",

issn = "2152-2669",

publisher = "Cancer Media Group",

number = "11",

}

TY - JOUR

T1 - Myelomatous Involvement of the Central Nervous System

AU - Paludo, Jonas

AU - Painuly, Utkarsh

AU - Kumar, Shaji K

AU - Gonsalves, Wilson

AU - Rajkumar, S Vincent

AU - Buadi, Francis

AU - Lacy, Martha

AU - Dispenzieri, Angela

AU - Kyle, Robert A.

AU - Mauermann, Michelle M

AU - McCurdy, Arleigh

AU - Dingli, David M

AU - Go, Ronald S.

AU - Hayman, Suzanne R.

AU - Leung, Nelson

AU - Lust, John A.

AU - Lin, Yi

AU - Gertz, Morie

AU - Kapoor, Prashant

PY - 2016/11/1

Y1 - 2016/11/1

N2 - Micro-Abstract Myelomatous involvement of the central nervous system (CNS) is an uncommon complication that portends a poor prognosis in patients with multiple myeloma (MM). Limited data exist regarding the optimal management of CNS MM. In the present case-control study, we examined the clinical presentation, diagnosis, treatment, and outcomes of CNS MM patients compared with a control group of MM patients without CNS involvement, matched by date of diagnosis and gender.

AB - Micro-Abstract Myelomatous involvement of the central nervous system (CNS) is an uncommon complication that portends a poor prognosis in patients with multiple myeloma (MM). Limited data exist regarding the optimal management of CNS MM. In the present case-control study, we examined the clinical presentation, diagnosis, treatment, and outcomes of CNS MM patients compared with a control group of MM patients without CNS involvement, matched by date of diagnosis and gender.

KW - Extramedullary

KW - High-risk

KW - Leptomeningeal

KW - Multiple myeloma

KW - Outcome

UR - http://www.scopus.com/inward/record.url?scp=84994545294&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84994545294&partnerID=8YFLogxK

U2 - 10.1016/j.clml.2016.08.010

DO - 10.1016/j.clml.2016.08.010

M3 - Article

C2 - 27624224

AN - SCOPUS:84994545294

VL - 16

SP - 644

EP - 654

JO - Clinical Lymphoma, Myeloma and Leukemia

JF - Clinical Lymphoma, Myeloma and Leukemia

SN - 2152-2669

IS - 11

ER -